Overview

Psychotherapy for Ketamine's Enhanced Durability in Chronic Neuropathic Pain: A Randomized Controlled Pilot Trial

Status:
Not yet recruiting

Trial end date:
2026-08-15

Target enrollment:

Participant gender:

Summary

The purpose of the study is to investigate new therapies to alleviate pain on neuropathic chronic pain. At this time, the main purpose is to complete a feasibility or pilot study with 60 participants suffering from neuropathic chronic pain. Participants will be randomized to (1) Ketamine HL; (2) psychotherapy (using Cognitive Behavioral Therapy); or (3) a combination of Ketamine HL and psychotherapy.

Phase:

Phase 4

Details

Lead Sponsor:

Akash Goel

Collaborator:

Unity Health Toronto

Treatments:

Ketamine